Your browser doesn't support javascript.
loading
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients.
Mohindroo, Chirayu; Hasanov, Merve; Rogers, Jane E; Dong, Wenli; Prakash, Laura R; Baydogan, Seyda; Mizrahi, Jonathan D; Overman, Michael J; Varadhachary, Gauri R; Wolff, Robert A; Javle, Milind M; Fogelman, David R; Lotze, Michael T; Kim, Michael P; Katz, Matthew H G; Pant, Shubham; Tzeng, Ching-Wei D; McAllister, Florencia.
Afiliação
  • Mohindroo C; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hasanov M; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Rogers JE; Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dong W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Prakash LR; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Baydogan S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mizrahi JD; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Varadhachary GR; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wolff RA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Javle MM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Fogelman DR; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lotze MT; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Kim MP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pant S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tzeng CD; Department of Investigation Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • McAllister F; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Cancer Med ; 10(15): 5041-5050, 2021 08.
Article em En | MEDLINE | ID: mdl-34250759
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Infecções Bacterianas / Carcinoma Ductal Pancreático / Microbioma Gastrointestinal / Intervalo Livre de Progressão / Antibacterianos / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Infecções Bacterianas / Carcinoma Ductal Pancreático / Microbioma Gastrointestinal / Intervalo Livre de Progressão / Antibacterianos / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article